FDA Will Limit Approvals for Covid-19 Shots. Moderna Stock Soars.
In This Article:
The Food and Drug Administration will only stick to its existing process for updating Covid-19 shots for older adults and those at a high risk of severe illness, the agency’s head wrote in a medical journal article on Tuesday. To get new Covid-19 shots approved for younger, healthy adults, drugmakers will need to run new randomized clinical trials, FDA Commissioner Dr. Marty Makary wrote. Moderna shares were up 7.8% to $28.46 in midday trading.
Terms and Privacy Policy